camonagrel has been researched along with Lung Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartuś, JB; Gryglewski, RJ; Wołkow, PP | 1 |
1 other study(ies) available for camonagrel and Lung Diseases
| Article | Year |
|---|---|
Pneumotoxicity of lipopolysaccharide in nitric oxide-deficient rats is limited by a thromboxane synthase inhibitor.
Topics: Animals; Blood Pressure; Epoprostenol; Escherichia coli; Indans; Lipopolysaccharides; Lung Diseases; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane-A Synthase | 1997 |